Short Interest in Synaptogenix, Inc. (NASDAQ:SNPX) Rises By 183.2%

Synaptogenix, Inc. (NASDAQ:SNPX) saw a significant growth in short interest in April. As of April 15th, there was short interest totalling 33,700 shares, a growth of 183.2% from the March 31st total of 11,900 shares. Based on an average daily trading volume, of 48,500 shares, the short-interest ratio is currently 0.7 days. Currently, 3.2% of the shares of the company are short sold.

Synaptogenix Trading Up 2.7 %

Shares of Synaptogenix stock traded up $0.12 during trading hours on Friday, reaching $4.53. The stock had a trading volume of 6,926 shares, compared to its average volume of 74,924. The stock’s 50 day moving average is $4.79 and its 200 day moving average is $5.85. Synaptogenix has a twelve month low of $3.53 and a twelve month high of $47.00. The firm has a market capitalization of $4.92 million, a PE ratio of -0.17 and a beta of 1.33.

About Synaptogenix

Synaptogenix, Inc operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease.